Table 1.
Review of publications presenting the latest developments in drug-eluting stents (DES).
| Authors | Year | Title | Abstract | Ref. |
|---|---|---|---|---|
| Chen et al. | 2016 | Coronary stent technology: a narrative review | A description of the evolution of coronary stent technology, the efficacy and safety of currently available devices, and the rationales for new-generation techniques in this domain. | [1] |
| Htay et al. | 2005 | Drug-Eluting Stent: A Review and Update | A summary of the recent development and progress of drug-eluting stents, followed by the results of their clinical trials. | [21] |
| Burt et al. | 2006 | Drug-eluting stents: A multidisciplinary success story | A comprehensive view of the disciplines related to the design and the development of drug-eluting stents, followed by a discussion on future directions in this domain. | [22] |
| Martin et al. | 2011 | Drug-eluting stents for coronary artery disease: A review | A review of both approved and most-promising proposals of drug-eluting stents. The study is a starting point for an indicator of the ways of the evolution of drug-eluting stents. | [23] |
| Doostzadeh et al. | 2010 | Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents focuses on the XIENCE V drug-eluting stent. | A discussion of clinical outcomes of drug-elution stents: clinical trials and development problems, design methods, and critical features, followed by an analysis of the future of this domain | [24] |
| Silber et al. | 2008 | Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials | A review is summarizing the results of clinical trials and analysis for patients with coronary artery disease and parallel diabetosis. | [25] |
| Li et al. | 2011 | Recent developments in drug-eluting stents | A summary of recent developments of drug-eluting stents as a base for novel methods in the management of symptomatic coronary artery disease, followed by a discussion of problems associated with the usage of this technology. | [26] |
| Buchanan et al. | 2017 | Does the new generation of drug-eluting stents render bare-metal stents obsolete? | A review of the literature devoted to the safety and efficacy of drug-eluting stents and a comparison of this technique with bare-metal stents. | [27] |
| Fusaro et al. | 2013 | Drug-eluting stents for revascularization of infrapopliteal arteries: an updated meta-analysis of randomized trials | An updated meta-analysis of randomized trials investigating the outcomes of percutaneous revascularization with primary drug-eluting stenting in patients with atherosclerotic disease of infrapopliteal arteries. | [28] |
| Shlofmitz et al. | 2019 | Restenosis of Drug-Eluting Stents: A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review | A new classification of in-stent restenosis by different mechanical, biological, and mixed etiologies, to enable individual treating of patients with drug-eluting stents to improve clinical outcome. | [29] |
| Wiesinger et al. | 2019 | Future developments in ureteral stents | A review of recent literature to summarize the most recent evidence on the use of ureteral stents, including the use of different materials and treatment of stent-related symptoms. | [30] |
| Lukman et al. | 2019 | Emerging of cardiovascular metal stent: A review on drug-eluting stent towards the utilization of herbal coating | A review of the utilization of various drugs as coating materials in identifying a possible alternative to overcome the current complications of DES. The discussion was divided into three sections: Stent; Commercial drug coating on DES; Herb coating on DES for cardiovascular application. | [31] |
| Wu et al. | 2019 | Polymer-free versus durable polymer drug-eluting stents in patients with coronary artery disease: A meta-analysis | A meta-analysis of randomized controlled trials to evaluate the safety and efficacy profiles of polymer-free drug-eluting stents compared with durable polymer drug-eluting stents. | [32] |
| Kommineni et al. | 2018 | Nonpolymer drug-eluting coronary stents | A review of nonpolymer drug-eluting stents loaded with different drugs like anti-inflammatory agents, antithrombotic, antiplatelet agents, immune suppressants, and others, followed by a description of surface modification techniques on stents like crystalline coating; microporous, macroporous, and nanoporous coatings; and chemically modified self-assembled monolayers. | [33] |
| Livingston et al. | 2019 | Coating Techniques and Release Kinetics of Drug-Eluting Stents | A review paper discusses recent drug-eluting stents designs utilizing individual or a combination of several coating techniques and their resulting drug-release profiles. | [34] |